Provenance Biopharmaceuticals' Partnership

Provenance Biopharmaceuticals raised a round of funding on December 27, 2011. Investors include Alopexx Enterprises.

Provenance Biopharmaceuticals is a clinical-stage biotechnology company focused on developing therapeutics for cancer and other serious, life-threatening diseases. The Company's engineered antibody te…

Articles about Provenance Biopharmaceuticals' Partnership: